Anavex Life Sciences (AVXL) PT Lowered to $40 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts AVXL Hot Sheet
Price: $3.56 +14.47%
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Join SI Premium – FREE
H.C. Wainwright analyst Raghuram Selvaraju lowered the price target on Anavex Life Sciences (NASDAQ: AVXL) to $40.00 (from $54.00) while maintaining a Buy rating.
You May Also Be Interested In
- Anavex Life Sciences Reports Third Fiscal Quarter 2026 Financial Results and Business Update
- Anjoy Foods Group (603345:CH) PT Lowered to RMB90.40 at Citi
- Jinxin Fertility Group Limited (1951:HK) (JXFGF) PT Lowered to HK$2.20 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
